- Status Report
- Jan 26, 2023
NASA Notice of Intent to Grant Partially Exclusive License: ENDO Medical Inc.
[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)] [Notices] [Page 92858] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2016-30501]
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
Notice of Intent to Grant Partially Exclusive License
AGENCY: National Aeronautics and Space Administration.
ACTION: Notice of Intent to Grant Partially Exclusive License.
SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive, license in the United States to practice the inventions described and claimed in U.S. Patent No. 7,623,972 entitled “Detection of Presence of Chemical Precursors”; U.S. Patent No. 7,801,687 entitled “Chemical Sensors Using Coated Or Doped Carbon Nanotube Networks”; U.S. Patent No. 7,968,054 entitled “Nanostructure Sensing and Transmission of Gas Data”; U.S. Patent No. 8,000,903 entitled “Coated or Doped Carbon Nanotube Network Sensors as Affected by Environmental Parameters”; ARC-16292-1 entitled “Nanosensor/Cell Phone Hybrid for Detecting Chemicals and Concentrations”; ARC-16902-1, entitled “Nanosensor for Medical Diagnoses”; ARC-17110-1 entitled “Detection of Gases and Vapors at Low Concentrations” to ENDO Medical Inc., having its principal place of business at 2345 Yale Street, 1st Floor, Palo Alto, CA 94306. The patent rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
DATES: The prospective partially exclusive license may be granted unless, within fifteen (15) days from the date of this published notice, NASA receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will also be treated as objections to the grant of the contemplated partially exclusive license.
Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552.
ADDRESSES: Objections relating to the prospective license may be submitted to Patent Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 202A-4, Moffett Field, CA 94035-1000. (650) 604-5104; Fax (650) 604-2767.
FOR FURTHER INFORMATION CONTACT: Robert M. Padilla, Chief Patent Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 202A-4, Moffett Field, CA 94035-1000. (650) 604-5104; Fax (650) 604- 2767. Information about other NASA inventions available for licensing can be found online at http://technology.nasa.gov/ .
Mark P. Dvorscak, Agency Counsel for Intellectual Property. [FR Doc. 2016-30501 Filed 12-19-16; 8:45 am] BILLING CODE 7510-13-P